<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34984651</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-7479</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</Title><ISOAbbreviation>Neurotherapeutics</ISOAbbreviation></Journal><ArticleTitle>Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>274</StartPage><EndPage>288</EndPage><MedlinePgn>274-288</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13311-021-01159-7</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease where muscle weakness and neuromuscular junction (NMJ) denervation precede motor neuron cell death. Although acetylcholine is the canonical neurotransmitter at the mammalian NMJ synapse, glutamate has recently been identified as a critical neurotransmitter for NMJ development and maintenance. One source of glutamate is through the catabolism of N-acetyl-aspartyl-glutamate (NAAG), which is found in mM concentrations in mammalian motoneurons, where it is released upon stimulation and hydrolyzed to glutamate by the glial enzyme glutamate carboxypeptidase II (GCPII). Using the SOD1<sup>G93A</sup> model of ALS, we found an almost fourfold elevation of GCPII enzymatic activity in SOD1<sup>G93A</sup> versus WT muscle and a robust increase in GCPII expression which was specifically associated with activated macrophages infiltrating the muscle. 2-(Phosphonomethyl)pentanedioic acid (2PMPA) is a potent GCPII inhibitor which robustly blocks glutamate release from NAAG but is highly polar with limited tissue penetration. To improve this, we covalently attached 2PMPA to a hydroxyl polyamidoamine (PAMAM-G4-OH) dendrimer delivery system (D-2PMPA) which is known to target activated macrophages in affected tissues. Systemic D-2PMPA therapy (20&#xa0;mg/kg 2PMPA equivalent; IP 2&#x2009;&#xd7;&#x2009;/week) was found to localize in muscle macrophages in SOD1<sup>G93A</sup> mice and completely normalize the enhanced GCPII activity. Although no changes in body weight or survival were observed, D-2PMPA significantly improved grip strength and inhibited the loss of NMJ innervation in the gastrocnemius muscles. Our finding that inhibiting elevated GCPII activity in SOD1<sup>G93A</sup> muscle can prolong muscle function and delay NMJ denervation may have early therapeutic implications for ALS patients.</AbstractText><CopyrightInformation>&#xa9; 2021. The American Society for Experimental NeuroTherapeutics, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tallon</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Anjali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Nanomedicine-Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Center for Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Natural Sciences, University of Michigan-Dearborn, Dearborn, MI, 48128, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Ajit G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xiaolei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Science, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donoghue</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulte</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joe</LastName><ForeName>Tawnjerae R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kambhampati</LastName><ForeName>Siva P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Center for Nanomedicine-Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Rishi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Nanomedicine-Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Nanomedicine-Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kannan</LastName><ForeName>Sujatha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hugo W. Moser Research Institute at Kennedy-Krieger, Inc, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kannan</LastName><ForeName>Rangaramanujam M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Center for Nanomedicine-Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hugo W. Moser Research Institute at Kennedy-Krieger, Inc, Baltimore, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, Johns Hopkins University School of Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slusher</LastName><ForeName>Barbara S</ForeName><Initials>BS</Initials><Identifier Source="ORCID">0000-0001-9814-4157</Identifier><AffiliationInfo><Affiliation>Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, USA. bslusher@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA. bslusher@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, USA. bslusher@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA. bslusher@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, USA. bslusher@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Science, Johns Hopkins University School of Medicine, Baltimore, USA. bslusher@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, 855 N. Wolfe Street, Rangos 278, Baltimore, MD, 21205, USA. bslusher@jhmi.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 AT010984</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG068130</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R25 GM109441</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS113140</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS093416</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurotherapeutics</MedlineTA><NlmUniqueID>101290381</NlmUniqueID><ISSNLinking>1878-7479</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050091">Dendrimers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005971">Glutamates</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050091" MajorTopicYN="Y">Dendrimers</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003714" MajorTopicYN="N">Denervation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005971" MajorTopicYN="N">Glutamates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Dendrimer</Keyword><Keyword MajorTopicYN="N">Glutamate</Keyword><Keyword MajorTopicYN="N">Glutamate carboxypeptidase II (GCPII)</Keyword><Keyword MajorTopicYN="N">N-acetyl-aspartyl-glutamate (NAAG)</Keyword><Keyword MajorTopicYN="N">NMDA</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">Neuromuscular junction (NJM)</Keyword><Keyword MajorTopicYN="N">mGluR3</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34984651</ArticleId><ArticleId IdType="pmc">PMC9130402</ArticleId><ArticleId IdType="doi">10.1007/s13311-021-01159-7</ArticleId><ArticleId IdType="pii">10.1007/s13311-021-01159-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cleveland DW, Rothstein JD. From charcot to lou gehrig: deciphering selective motor neuron death in als. Nature Reviews Neuroscience. 2001;2(11):806&#x2013;819. doi: 10.1038/35097565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35097565</ArticleId><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B, Gendron TF, Staff NP. Amyotrophic Lateral Sclerosis: An Update for 2018. Mayo Clin Proc. 2018;93(11):1617&#x2013;1628. doi: 10.1016/j.mayocp.2018.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2018.04.007</ArticleId><ArticleId IdType="pubmed">30401437</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz M, Leclerc N, Gurney M, Warter J-M, Poindron P, Borg J. Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis. Muscle &amp; Nerve. 1997;20(1):45&#x2013;51. doi: 10.1002/(SICI)1097-4598(199701)20:1&lt;45::AID-MUS6&gt;3.0.CO;2-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(199701)20:1&lt;45::AID-MUS6&gt;3.0.CO;2-H</ArticleId><ArticleId IdType="pubmed">8995582</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Experimental Neurology. 2004;185(2):232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T. Time course of preferential motor unit loss in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease. 2007;28(2):154&#x2013;164. doi: 10.1016/j.nbd.2007.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.07.003</ArticleId><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallon C, Russell KA, Sakhalkar S, Andrapallayal N, Farah MH. Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice. Neuroscience. 2016;312:179&#x2013;189. doi: 10.1016/j.neuroscience.2015.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.11.018</ArticleId><ArticleId IdType="pmc">PMC4691388</ArticleId><ArticleId IdType="pubmed">26592719</ArticleId></ArticleIdList></Reference><Reference><Citation>Personius KE, Slusher BS, Udin SB. Neuromuscular NMDA Receptors Modulate Developmental Synapse Elimination. J Neurosci. 2016;36(34):8783&#x2013;8789. doi: 10.1523/JNEUROSCI.1181-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1181-16.2016</ArticleId><ArticleId IdType="pmc">PMC6601906</ArticleId><ArticleId IdType="pubmed">27559162</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MB, Blakely RD, Couto R, Coyle JT. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. Journal of Biological Chemistry. 1987;262(30):14498&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">3667587</ArticleId></ArticleIdList></Reference><Reference><Citation>Slusher BS, Robinson MB, Tsai G, Simmons ML, Richards SS, Coyle JT. Rat brain N-acetylated alpha-linked acidic dipeptidase activity. Purification and immunologic characterization. Journal of Biological Chemistry. 1990;265(34):21297&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">2250024</ArticleId></ArticleIdList></Reference><Reference><Citation>Neale JH. N-acetylaspartylglutamate is an agonist at mGluR3 in vivo and in vitro. Journal of neurochemistry. 2011;119(5):891&#x2013;895. doi: 10.1111/j.1471-4159.2011.07380.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07380.x</ArticleId><ArticleId IdType="pmc">PMC3202081</ArticleId><ArticleId IdType="pubmed">21740441</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature. 1984;309(5965):261&#x2013;263. doi: 10.1038/309261a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/309261a0</ArticleId><ArticleId IdType="pubmed">6325946</ArticleId></ArticleIdList></Reference><Reference><Citation>Volianskis A, France G, Jensen MS, Bortolotto ZA, Jane DE, Collingridge GL. Long-term potentiation and the role of N-methyl-D-aspartate receptors. Brain research. 2015;1621:5&#x2013;16. doi: 10.1016/j.brainres.2015.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.01.016</ArticleId><ArticleId IdType="pmc">PMC4563944</ArticleId><ArticleId IdType="pubmed">25619552</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger UV, Carter RE, Coyle JT. The immunocytochemical localization of N-acetylaspartyl glutamate, its hydrolysing enzyme NAALADase, and the NMDAR-1 receptor at a vertebrate neuromuscular junction. Neuroscience. 1995;64(4):847&#x2013;850. doi: 10.1016/0306-4522(95)92578-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(95)92578-8</ArticleId><ArticleId IdType="pubmed">7753384</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson PF, Cole DC, Slusher BS, Stetz SL, Ross LE, Donzanti BA, et al. Design, Synthesis, and Biological Activity of a Potent Inhibitor of the Neuropeptidase N-Acetylated &#x3b1;-Linked Acidic Dipeptidase. Journal of Medicinal Chemistry. 1996;39(2):619&#x2013;622. doi: 10.1021/jm950801q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm950801q</ArticleId><ArticleId IdType="pubmed">8558536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Neale JH, Pomper MG, Kozikowski AP. NAAG peptidase inhibitors and their potential for diagnosis and therapy. Nature Reviews Drug Discovery. 2005;4(12):1015&#x2013;1026. doi: 10.1038/nrd1903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd1903</ArticleId><ArticleId IdType="pubmed">16341066</ArticleId></ArticleIdList></Reference><Reference><Citation>Vornov JJ, Hollinger KR, Jackson PF, Wozniak KM, Farah MH, Majer P, et al. Chapter Nine - Still NAAG&#x2019;ing After All These Years: The Continuing Pursuit of GCPII Inhibitors. In: Schwarcz R, editor. Advances in Pharmacology. 76: Academic Press; 2016. p. 215&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">27288079</ArticleId></ArticleIdList></Reference><Reference><Citation>Rais R, Wozniak K, Wu Y, Niwa M, Stathis M, Alt J, et al. Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration. PLOS ONE. 2015;10(7):e0131861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4494705</ArticleId><ArticleId IdType="pubmed">26151906</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Post JP, de Visser SJ, de Kam ML, Woelfler M, Hilt DC, Vornov J, et al. The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693. Br J Clin Pharmacol. 2005;60(2):128&#x2013;136. doi: 10.1111/j.1365-2125.2005.02396.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.2005.02396.x</ArticleId><ArticleId IdType="pmc">PMC1884920</ArticleId><ArticleId IdType="pubmed">16042665</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffe IA. Adverse effects profile of sulfhydryl compounds in man. The American Journal of Medicine. 1986;80(3):471&#x2013;476. doi: 10.1016/0002-9343(86)90722-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(86)90722-9</ArticleId><ArticleId IdType="pubmed">2937293</ArticleId></ArticleIdList></Reference><Reference><Citation>Hari NP, Umashankar D, Rajendra KS, Jonathan RD. Cytotoxic Thiol Alkylators. Mini-Reviews in Medicinal Chemistry. 2007;7(2):131&#x2013;139. doi: 10.2174/138955707779802642.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138955707779802642</ArticleId><ArticleId IdType="pubmed">17305587</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith ES, Porterfield JE, Kannan RM. Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders. Advanced drug delivery reviews. 2019;148:181&#x2013;203. doi: 10.1016/j.addr.2019.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2019.02.009</ArticleId><ArticleId IdType="pmc">PMC7043366</ArticleId><ArticleId IdType="pubmed">30844410</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Lin Y-A, Kannan S, Kannan RM. Targeting specific cells in the brain with nanomedicines for CNS therapies. J Control Release. 2016;240:212&#x2013;226. doi: 10.1016/j.jconrel.2015.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2015.12.013</ArticleId><ArticleId IdType="pmc">PMC4903089</ArticleId><ArticleId IdType="pubmed">26686078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollinger KR, Sharma A, Tallon C, Lovell L, Thomas AG, Zhu X, et al. Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis. Nanotheranostics. 2022;6(2):126&#x2013;142. doi: 10.7150/ntno.63158.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ntno.63158</ArticleId><ArticleId IdType="pmc">PMC8671953</ArticleId><ArticleId IdType="pubmed">34976589</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Porterfield JE, Smith E, Sharma R, Kannan S, Kannan RM. Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model. Journal of Controlled Release. 2018;283:175&#x2013;189. doi: 10.1016/j.jconrel.2018.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2018.06.003</ArticleId><ArticleId IdType="pmc">PMC6091673</ArticleId><ArticleId IdType="pubmed">29883694</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra MK, Beaty CA, Lesniak WG, Kambhampati SP, Zhang F, Wilson MA, et al. Dendrimer Brain Uptake and Targeted Therapy for Brain Injury in a Large Animal Model of Hypothermic Circulatory Arrest. ACS Nano. 2014;8(3):2134&#x2013;2147. doi: 10.1021/nn404872e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/nn404872e</ArticleId><ArticleId IdType="pmc">PMC4004292</ArticleId><ArticleId IdType="pubmed">24499315</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Sharma R, Zhang Z, Liaw K, Kambhampati SP, Porterfield JE, et al. Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders. Science Advances. 2020;6(4):eaay8514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6976300</ArticleId><ArticleId IdType="pubmed">32010790</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Kim S-Y, Sharma A, Zhang Z, Kambhampati SP, Kannan S, et al. Activated Microglia Targeting Dendrimer-Minocycline Conjugate as Therapeutics for Neuroinflammation. Bioconjugate Chemistry. 2017;28(11):2874&#x2013;2886. doi: 10.1021/acs.bioconjchem.7b00569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.bioconjchem.7b00569</ArticleId><ArticleId IdType="pmc">PMC6023550</ArticleId><ArticleId IdType="pubmed">29028353</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu. Zn superoxide dismutase mutation. Science. 1994;264(5166):1772&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, Deitch JS, Blankenhorn EP, Erwin KL, Perreault MJ, Alexander BK, et al. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. Journal of the Neurological Sciences. 2005;236(1):1&#x2013;7. doi: 10.1016/j.jns.2005.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.02.006</ArticleId><ArticleId IdType="pubmed">16024047</ArticleId></ArticleIdList></Reference><Reference><Citation>Nance E, Kambhampati SP, Smith ES, Zhang Z, Zhang F, Singh S, et al. Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome. Journal of neuroinflammation. 2017;14(1):252-.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5735803</ArticleId><ArticleId IdType="pubmed">29258545</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore AC, Haenggeli C, Gasmi M, Bishop KM, Bartus RT, Maragakis NJ, et al. Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS. Brain Research. 2007;1185:256&#x2013;265. doi: 10.1016/j.brainres.2007.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.09.034</ArticleId><ArticleId IdType="pmc">PMC2265207</ArticleId><ArticleId IdType="pubmed">17963733</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas C, Frazier ST, Flanary J, Slusher BS. Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay. Anal Biochem. 2002;310(1):50&#x2013;54. doi: 10.1016/S0003-2697(02)00286-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-2697(02)00286-5</ArticleId><ArticleId IdType="pubmed">12413472</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird FM, Farah MH, Ackerley S, Hoke A, Maragakis N, Rothstein JD, et al. Motor Neuron Disease Occurring in a Mutant Dynactin Mouse Model Is Characterized by Defects in Vesicular Trafficking. The Journal of Neuroscience. 2008;28(9):1997&#x2013;2005. doi: 10.1523/JNEUROSCI.4231-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4231-07.2008</ArticleId><ArticleId IdType="pmc">PMC6671836</ArticleId><ArticleId IdType="pubmed">18305234</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardo AC, Wong V, Benson LM, Dykes M, Tanaka K, Rothstein JD, et al. Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1G93A mice. Experimental Neurology. 2006;201(1):120&#x2013;130. doi: 10.1016/j.expneurol.2006.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2006.03.028</ArticleId><ArticleId IdType="pubmed">16753145</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, Smyth GK. Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics. 2007;9(2):321&#x2013;332. doi: 10.1093/biostatistics/kxm030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/kxm030</ArticleId><ArticleId IdType="pubmed">17728317</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26(1):139&#x2013;140. doi: 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Nedelcovych MT, Thomas AG, Hasegawa Y, Moreno-Megui A, Coomer W, et al. JHU-083 selectively blocks glutaminase activity in brain CD11b(+) cells and prevents depression-associated behaviors induced by chronic social defeat stress. Neuropsychopharmacology. 2019;44(4):683&#x2013;694. doi: 10.1038/s41386-018-0177-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-018-0177-7</ArticleId><ArticleId IdType="pmc">PMC6372721</ArticleId><ArticleId IdType="pubmed">30127344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto S, Mallah D, Medeiros DJ, Dohi E, Imai T, Rose IVL, et al. Alterations in circulating extracellular vesicles underlie social stress-induced behaviors in mice. FEBS Open Bio. 2021;11(10):2678&#x2013;2692. doi: 10.1002/2211-5463.13204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.13204</ArticleId><ArticleId IdType="pmc">PMC8487053</ArticleId><ArticleId IdType="pubmed">34043886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolb HC, Finn MG, Sharpless KB. Click Chemistry: Diverse Chemical Function from a Few Good Reactions. Angewandte Chemie International Edition. 2001;40(11):2004&#x2013;2021. doi: 10.1002/1521-3773(20010601)40:11&lt;2004::AID-ANIE2004&gt;3.0.CO;2-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1521-3773(20010601)40:11&lt;2004::AID-ANIE2004&gt;3.0.CO;2-5</ArticleId><ArticleId IdType="pubmed">11433435</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Sharma A, Kambhampati SP, Reddy RR, Zhang Z, Cleland JL, et al. Scalable synthesis and validation of PAMAM dendrimer-N-acetyl cysteine conjugate for potential translation. Bioeng Transl Med. 2018;3(2):87&#x2013;101. doi: 10.1002/btm2.10094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/btm2.10094</ArticleId><ArticleId IdType="pmc">PMC6063872</ArticleId><ArticleId IdType="pubmed">30065965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambhampati SP, Mishra MK, Mastorakos P, Oh Y, Lutty GA, Kannan RM. Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells. Eur J Pharm Biopharm. 2015;95(Pt B):239&#x2013;249. doi: 10.1016/j.ejpb.2015.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpb.2015.02.013</ArticleId><ArticleId IdType="pmc">PMC4861086</ArticleId><ArticleId IdType="pubmed">25701805</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Nance E, Zhang Z, Jasty V, Kambhampati SP, Mishra MK, et al. Surface functionality affects the biodistribution and microglia-targeting of intra-amniotically delivered dendrimers. J Control Release. 2016;237:61&#x2013;70. doi: 10.1016/j.jconrel.2016.06.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2016.06.046</ArticleId><ArticleId IdType="pmc">PMC5380001</ArticleId><ArticleId IdType="pubmed">27378700</ArticleId></ArticleIdList></Reference><Reference><Citation>Nance E, Zhang F, Mishra MK, Zhang Z, Kambhampati SP, Kannan RM, et al. Nanoscale effects in dendrimer-mediated targeting of neuroinflammation. Biomaterials. 2016;101:96&#x2013;107. doi: 10.1016/j.biomaterials.2016.05.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2016.05.044</ArticleId><ArticleId IdType="pmc">PMC5379995</ArticleId><ArticleId IdType="pubmed">27267631</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Liaw K, Sharma A, Jimenez A, Chang M, Salazar S, et al. Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma. Journal of Controlled Release. 2021;337:179&#x2013;192. doi: 10.1016/j.jconrel.2021.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8600682</ArticleId><ArticleId IdType="pubmed">34274384</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Trent Magruder J, Lin Y-A, Crawford TC, Grimm JC, Sciortino CM, et al. Generation-6 hydroxyl PAMAM dendrimers improve CNS penetration from intravenous administration in a large animal brain injury model. J Control Release. 2017;249:173&#x2013;182. doi: 10.1016/j.jconrel.2017.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2017.01.032</ArticleId><ArticleId IdType="pmc">PMC5323327</ArticleId><ArticleId IdType="pubmed">28137632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesniak WG, Mishra MK, Jyoti A, Balakrishnan B, Zhang F, Nance E, et al. Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation. Mol Pharm. 2013;10(12):4560&#x2013;4571. doi: 10.1021/mp400371r.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/mp400371r</ArticleId><ArticleId IdType="pmc">PMC3977004</ArticleId><ArticleId IdType="pubmed">24116950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraris DV, Majer P, Ni C, Slusher CE, Rais R, Wu Y, et al. delta-Thiolactones as prodrugs of thiol-based glutamate carboxypeptidase II (GCPII) inhibitors. J Med Chem. 2014;57(1):243&#x2013;247. doi: 10.1021/jm401703a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm401703a</ArticleId><ArticleId IdType="pmc">PMC3932958</ArticleId><ArticleId IdType="pubmed">24354364</ArticleId></ArticleIdList></Reference><Reference><Citation>Majer P, Jackson PF, Delahanty G, Grella BS, Ko Y-S, Li W, et al. Synthesis and Biological Evaluation of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II: Discovery of an Orally Active GCP II Inhibitor. Journal of Medicinal Chemistry. 2003;46(10):1989&#x2013;1996. doi: 10.1021/jm020515w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm020515w</ArticleId><ArticleId IdType="pubmed">12723961</ArticleId></ArticleIdList></Reference><Reference><Citation>Vornov JJ, Wozniak KM, Wu Y, Rojas C, Rais R, Slusher BS. Pharmacokinetics and pharmacodynamics of the glutamate carboxypeptidase II inhibitor 2-MPPA show prolonged alleviation of neuropathic pain through an indirect mechanism. J Pharmacol Exp Ther. 2013;346(3):406&#x2013;413. doi: 10.1124/jpet.113.205039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.113.205039</ArticleId><ArticleId IdType="pmc">PMC4186626</ArticleId><ArticleId IdType="pubmed">23776202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadge GD, Slusher BS, Bodner A, Canto MD, Wozniak K, Thomas AG, et al. Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(16):9554&#x2013;9559. doi: 10.1073/pnas.1530168100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1530168100</ArticleId><ArticleId IdType="pmc">PMC170956</ArticleId><ArticleId IdType="pubmed">12876198</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science (New York, NY). 2009;326(5959):1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Wooley CM, Sher RB, Kale A, Frankel WN, Cox GA, Seburn KL. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle &amp; nerve. 2005;32(1):43&#x2013;50. doi: 10.1002/mus.20228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20228</ArticleId><ArticleId IdType="pmc">PMC1350398</ArticleId><ArticleId IdType="pubmed">15880561</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo-Arozena A, Kalmar B, Essa S, Ricketts T, Joyce P, Kent R, et al. A comprehensive assessment of the &lt;em&gt;SOD1&lt;sup&gt;G93A&lt;/sup&gt;&lt;/em&gt; low-copy transgenic mouse, which models human amyotrophic lateral sclerosis. Disease Models &amp; Mechanisms. 2011;4(5):686&#x2013;700. doi: 10.1242/dmm.007237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.007237</ArticleId><ArticleId IdType="pmc">PMC3180233</ArticleId><ArticleId IdType="pubmed">21540242</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacabelos D, Ram&#xed;rez-N&#xfa;&#xf1;ez O, Granado-Serrano AB, Torres P, Ayala V, Moiseeva V, et al. Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS. Acta Neuropathologica Communications. 2016;4(1):3. doi: 10.1186/s40478-015-0271-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0271-6</ArticleId><ArticleId IdType="pmc">PMC4711180</ArticleId><ArticleId IdType="pubmed">26757991</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Cutting FB, Zhai P, Doble A, Taylor CP, Andrus PK, et al. Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis. Annals of Neurology. 1996;39(2):147&#x2013;157. doi: 10.1002/ana.410390203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390203</ArticleId><ArticleId IdType="pubmed">8967745</ArticleId></ArticleIdList></Reference><Reference><Citation>Snow RJ, Turnbull J, da Silva S, Jiang F, Tarnopolsky MA. Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice. Neuroscience. 2003;119(3):661&#x2013;667. doi: 10.1016/S0306-4522(03)00212-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(03)00212-4</ArticleId><ArticleId IdType="pubmed">12809687</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott S, Kranz JE, Cole J, Lincecum JM, Thompson K, Kelly N, et al. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotrophic Lateral Sclerosis. 2008;9(1):4&#x2013;15. doi: 10.1080/17482960701856300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701856300</ArticleId><ArticleId IdType="pubmed">18273714</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogg MC, Halang L, Woods I, Coughlan KS, Prehn JHM. Riluzole does not improve lifespan or motor function in three ALS mouse models. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2018;19(5&#x2013;6):438&#x2013;445. doi: 10.1080/21678421.2017.1407796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1407796</ArticleId><ArticleId IdType="pubmed">29221425</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Sung M, Rutkove SB. Electrophysiologic Biomarkers for Assessing Disease Progression and the Effect of Riluzole in SOD1 G93A ALS Mice. PLOS ONE. 2013;8(6):e65976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675066</ArticleId><ArticleId IdType="pubmed">23762454</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;&#xe1;cha P, Z&#xe1;me&#x10d;n&#xed;k J, Ba&#x159;inka C, Hlouchov&#xe1; K, V&#xed;cha A, Ml&#x10d;ochov&#xe1; P, et al. Expression of glutamate carboxypeptidase II in human brain. Neuroscience. 2007;144(4):1361&#x2013;1372. doi: 10.1016/j.neuroscience.2006.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2006.10.022</ArticleId><ArticleId IdType="pubmed">17150306</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger UV, Carter RE, McKee M, Coyle JT. N-acetylated alpha-linked acidic dipeptidase is expressed by non-myelinating Schwann cells in the peripheral nervous system. Journal of Neurocytology. 1995;24(2):99&#x2013;109. doi: 10.1007/BF01181553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01181553</ArticleId><ArticleId IdType="pubmed">7745446</ArticleId></ArticleIdList></Reference><Reference><Citation>Knedl&#xed;k T, Vorlov&#xe1; B, Navr&#xe1;til V, Tykvart J, Sedl&#xe1;k F, Vacul&#xed;n &#x160;, et al. Mouse glutamate carboxypeptidase II (GCPII) has a similar enzyme activity and inhibition profile but a different tissue distribution to human GCPII. FEBS Open Bio. 2017;7(9):1362&#x2013;1378. doi: 10.1002/2211-5463.12276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.12276</ArticleId><ArticleId IdType="pmc">PMC5586342</ArticleId><ArticleId IdType="pubmed">28904865</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Bassam B, Thomas AG, Williams M, Liu J, Nance E, et al. Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal/newborn rabbit brain. Neurobiology of Disease. 2016;94:116&#x2013;128. doi: 10.1016/j.nbd.2016.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.06.010</ArticleId><ArticleId IdType="pmc">PMC5394739</ArticleId><ArticleId IdType="pubmed">27326668</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheib J, H&#xf6;ke A. Advances in peripheral nerve regeneration. Nature Reviews Neurology. 2013;9(12):668&#x2013;676. doi: 10.1038/nrneurol.2013.227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.227</ArticleId><ArticleId IdType="pubmed">24217518</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P, Peng J, Han G-H, Ding X, Wei S, Gao G, et al. Role of macrophages in peripheral nerve injury and repair. Neural Regen Res. 2019;14(8):1335&#x2013;1342. doi: 10.4103/1673-5374.253510.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.253510</ArticleId><ArticleId IdType="pmc">PMC6524518</ArticleId><ArticleId IdType="pubmed">30964051</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Bender DE, Segal BM, Feldman EL. The dual roles of immunity in ALS: Injury overrides protection. Neurobiology of Disease. 2015;77:1&#x2013;12. doi: 10.1016/j.nbd.2015.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.02.017</ArticleId><ArticleId IdType="pubmed">25726748</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S, Shono J-i, Suzuki T, Sawano S, Anderson JE, Do M-KQ, et al. Implication of anti-inflammatory macrophages in regenerative moto-neuritogenesis: Promotion of myoblast migration and neural chemorepellent semaphorin 3A expression in injured muscle. The International Journal of Biochemistry &amp; Cell Biology. 2014;54:272&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">24886696</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dyke JM, Smit-Oistad IM, Macrander C, Krakora D, Meyer MG, Suzuki M. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS) Experimental neurology. 2016;277:275&#x2013;282. doi: 10.1016/j.expneurol.2016.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.01.008</ArticleId><ArticleId IdType="pmc">PMC4762214</ArticleId><ArticleId IdType="pubmed">26775178</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Gascon R, Miller RG, Gelinas DF, Mass J, Hadlock K, et al. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS) Journal of Neuroimmunology. 2005;159(1):215&#x2013;224. doi: 10.1016/j.jneuroim.2004.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2004.10.009</ArticleId><ArticleId IdType="pubmed">15652422</ArticleId></ArticleIdList></Reference><Reference><Citation>Yawata I, Takeuchi H, Doi Y, Liang J, Mizuno T, Suzumura A. Macrophage-induced neurotoxicity is mediated by glutamate and attenuated by glutaminase inhibitors and gap junction inhibitors. Life Sciences. 2008;82(21):1111&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18452953</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Caroni P. Mechanisms of axon degeneration: From development to disease. Progress in Neurobiology. 2007;83(3):174&#x2013;191. doi: 10.1016/j.pneurobio.2007.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2007.07.007</ArticleId><ArticleId IdType="pubmed">17822833</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen L, J&#xf8;rgensen LH, Bech RD, Frandsen U, Schr&#xf8;der HD. Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis. Biomed Res Int. 2016;2016:5930621-.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4852332</ArticleId><ArticleId IdType="pubmed">27195289</ArticleId></ArticleIdList></Reference><Reference><Citation>Groh J, Klein I, Hollmann C, Wettmarshausen J, Klein D, Martini R. CSF-1-activated macrophages are target-directed and essential mediators of schwann cell dedifferentiation and dysfunction in Cx32-deficient mice. Glia. 2015;63(6):977&#x2013;986. doi: 10.1002/glia.22796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22796</ArticleId><ArticleId IdType="pubmed">25628221</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X, Klein D, Kerscher S, West BL, Weis J, Katona I, et al. Macrophage depletion ameliorates peripheral neuropathy in aging mice. The Journal of Neuroscience. 2018:3030&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6705935</ArticleId><ArticleId IdType="pubmed">29712789</ArticleId></ArticleIdList></Reference><Reference><Citation>Rais R, Jiang W, Zhai H, Wozniak KM, Stathis M, Hollinger KR, et al. FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities. JCI Insight. 2016;1(12).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4985244</ArticleId><ArticleId IdType="pubmed">27536732</ArticleId></ArticleIdList></Reference><Reference><Citation>Neale JH, Yamamoto T. N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications. Progress in Neurobiology. 2020;184:101722.</Citation><ArticleIdList><ArticleId IdType="pubmed">31730793</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomlin H, Piccinini AM. A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens. Immunology. 2018;155(2):186&#x2013;201. doi: 10.1111/imm.12972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12972</ArticleId><ArticleId IdType="pmc">PMC6142291</ArticleId><ArticleId IdType="pubmed">29908065</ArticleId></ArticleIdList></Reference><Reference><Citation>de Luca AC, Lacour SP, Raffoul W, di Summa PG. Extracellular matrix components in peripheral nerve repair: how to affect neural cellular response and nerve regeneration? Neural Regen Res. 2014;9(22):1943&#x2013;1948. doi: 10.4103/1673-5374.145366.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.145366</ArticleId><ArticleId IdType="pmc">PMC4283273</ArticleId><ArticleId IdType="pubmed">25598773</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway RE, Rojas C, Alt J, Nov&#xe1;kov&#xe1; Z, Richardson SM, Rodrick TC, et al. Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide. Angiogenesis. 2016;19(4):487&#x2013;500. doi: 10.1007/s10456-016-9521-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-016-9521-x</ArticleId><ArticleId IdType="pubmed">27387982</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>